newsfilter
← Latest News
PR Newswire·

Theravance Biopharma Announces Approval of YUPELRI® (revefenacin) by China's NMPA

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that Viatris Inc. ("Viatris"), has secured...